Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H
Wall Street Journal
Novartis said the acquisition expands and complements its pipeline in oncology.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Novartis said the acquisition expands and complements its pipeline in oncology.